Screener / SEC EDGAR /CIK 0001521036 /10-K filed Feb 26, 2026, compared with Feb 26, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Health care · Diagnostics

Lantheus Holdings, Inc. LNTH

Compare with peers Embed
Planned sales, announced before they happen

1 trading plan running, 5 Form 144 notices for $2.7M

10-Q, 10-K and Form 144

What LNTH's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.

Plans adopted or ended

Trading plans · XBRL, 10-Q and 10-K

From Feb 28, 2025 to Nov 16, 2026. The thin line is today; a filled bar is a plan still running, a paler one has ended or expired. The ten newest plans are drawn; all are in the table.

InsiderWhatDateReported in
Daniel Niedzwiecki
Chief Administrative Officer, General Counsel and Corporate Secretary
Adopted 10b5-1 plan Mar 12, 2026 10-Q May 7, 2026
Samuel R. Leno
a member of our Board
Adopted 10b5-1 plan Mar 11, 2026 10-Q May 7, 2026
Julie McHugh
a member of our Board
Adopted 10b5-1 plan Mar 2, 2026 10-Q May 7, 2026
Samuel R. Leno
a member of our Board
Adopted 10b5-1 plan Dec 2, 2025 10-K Feb 26, 2026
Robert Marshall
CFO and Treasurer
Adopted 10b5-1 plan Mar 11, 2025 10-Q May 7, 2025
What the company wrote
On March 11, 2025, Robert Marshall, our CFO and Treasurer, entered into a 10b5-1 Plan providing for the potential sale of up to 39,773 shares of our common stock between June 9, 2025, and June 30, 2025.
Samuel R. Leno
member of our Board
Adopted 10b5-1 plan Mar 11, 2025 10-Q May 7, 2025
What the company wrote
On March 11, 2025, Samuel R. Leno, a member of our Board, entered into a 10b5-1 Plan providing for the potential sale of up to 14,307 shares of our common stock between June 11, 2025, and November 12, 2025.
Julie McHugh
member of our Board
Adopted 10b5-1 plan Mar 10, 2025 10-Q May 7, 2025
What the company wrote
On March 10, 2025, Julie McHugh, a member of our Board, entered into a 10b5-1 Plan providing for the potential sale of up to 5,192 shares of our common stock on June 9, 2025.
Daniel Niedzwiecki
Chief Administrative Officer, General Counsel and Corporate Secretary
Adopted 10b5-1 plan Mar 6, 2025 10-Q May 7, 2025
What the company wrote
On March 6, 2025, Daniel Niedzwiecki, our Chief Administrative Officer, General Counsel and Corporate Secretary, entered into a 10b5-1 Plan providing for the potential sale of up to 12,000 shares of our common stock between June 5, 2025, and July 7, 2025.
Mary Anne Heino
Chairperson of our Board
Adopted 10b5-1 plan Mar 3, 2025 10-Q May 7, 2025
What the company wrote
On March 3, 2025, Mary Anne Heino, the Chairperson of our Board, entered into a 10b5-1 Plan providing for the potential sale of shares of our common stock in an amount necessary to attain approximately net sale proceeds of $2,000,000 between June 2, 2025, and June 13, 2025. The 10b5-1 Plan also provides for the potential sale of up to 70,142 shares of our common stock between August 8, 2025, and March 13, 2026.
Paul Blanchfield
President
Adopted 10b5-1 plan Feb 28, 2025 10-Q May 7, 2025
What the company wrote
On February 28, 2025, Paul Blanchfield, our President, entered into a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act (a “10b5-1 Plan”). The 10b5-1 Plan provides for the potential sale of up to 29,271 shares of our common stock between June 5, 2025, and March 6, 2026. Pursuant to the 10b5-1 Plan, Mr. Blanchfield will also make a gift of 659 shares of common stock on November 14, 2025.
Robert Marshall
CFO and Treasurer
Adopted 10b5-1 plan Aug 12, 2024 10-Q Nov 6, 2024
What the company wrote
On August 12, 2024, Robert Marshall, our CFO and Treasurer, entered into a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act, providing for the potential sale of up to 20,000 shares of our common stock between November 15, 2024 and March 17, 2025.
James Thrall
member of our Board
Adopted 10b5-1 plan May 21, 2024 10-Q Jul 31, 2024
What the company wrote
On May 21, 2024, James Thrall, a member of our Board, entered into a 10b5-1 Plan providing for the potential sale of up to 2,000 shares of our common stock between August 21, 2024 and January 15, 2025.
Gérard Ber
member of our Board
Adopted 10b5-1 plan May 7, 2024 10-Q Jul 31, 2024
What the company wrote
On May 7, 2024, Gérard Ber, a member of our Board, entered into a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act (a “10b5-1 Plan”), providing for the potential sale of up to 15,500 shares of our common stock between September 11, 2024 and April 11, 2025.
Mary Anne Heino
member of our Board
Adopted 10b5-1 plan Mar 13, 2024 10-Q May 2, 2024
What the company wrote
On March 13, 2024, Mary Anne Heino, a member of our Board, entered into a 10b5-1 Plan. The plan provides for the sale of shares of our common stock between August 2, 2024 and March 31, 2025 in an amount (i) sufficient to cover tax withholding obligations in connection with the potential vesting and settlement of up to 117,006 outstanding RSUs and PSUs plus (ii) an additional number of shares necessary to result in approximate net sale proceeds of $2,000,000 in the aggregate.
Daniel Niedzwiecki
Chief Administrative Officer, General Counsel and Corporate Secretary
Adopted 10b5-1 plan Mar 1, 2024 10-Q May 2, 2024
What the company wrote
On March 1, 2024, Daniel Niedzwiecki, our Chief Administrative Officer, General Counsel and Corporate Secretary, entered into a 10b5-1 Plan providing for the potential sale of up to 15,373 shares of our common stock, between May 30, 2024 and August 30, 2024.
Paul Blanchfield
President
Adopted 10b5-1 plan Mar 1, 2024 10-Q May 2, 2024
What the company wrote
On March 1, 2024, Paul Blanchfield, our President, entered into a 10b5-1 Plan providing for the potential sale of up to 7,263 shares of our common stock, between May 31, 2024 and March 5, 2025. Pursuant to the 10b5-1 Plan, Mr. Blanchfield will also make a gift of 355 shares of common stock on November 14, 2024.
Heinz Mäusli
member of our Board
Adopted 10b5-1 plan Feb 27, 2024 10-Q May 2, 2024
What the company wrote
On February 27, 2024, Heinz Mäusli, a member of our Board, entered into a 10b5-1 Plan providing for the potential sale of up to 25,692 shares of our common stock, including shares obtained from the exercise of vested stock options covered by the 10b5-1 Plan, between May 28, 2024 and September 30, 2024.
Julie McHugh
member of our Board
Adopted plan Feb 26, 2024 10-Q May 2, 2024
What the company wrote
On February 26, 2024, Julie McHugh, a member of our Board, entered into a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act (a “10b5-1 Plan”), providing for the potential sale of up to 2,500 shares of our common stock on May 28, 2024.
Sam Leno
member of our Board
Adopted 10b5-1 plan Nov 29, 2023 10-K Feb 22, 2024
What the company wrote
On November 7, 2023, Sam Leno, a member of our Board, entered into a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act (a “10b5-1 Plan”), providing for the potential sale of up to 2,045 shares of our common stock obtained from the exercise of vested stock options covered by the 10b5-1 Plan, between March 4, 2024 and May 15, 2024. On November 29, 2023, Mr. Leno amended his 10b5-1 Plan to add the potential sale of up to 20,344 additional shares of our common stock obtained from the exercise of vested stock options covered by the 10b5-1 Plan, between March 4, 2024 and May 15, 2024.
Robert Marshall
Chief Financial Officer and Treasurer
Adopted 10b5-1 plan Aug 30, 2023 10-Q Nov 2, 2023
What the company wrote
On August 30, 2023, Robert Marshall, our Chief Financial Officer and Treasurer, entered into a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act (a “10b5-1 Plan”), providing for the potential sale of up to 30,000 shares of our common stock between December 15, 2023 and August 9, 2024.
Andrea Sabens
Chief Accounting Officer
Adopted 10b5-1 plan Aug 11, 2023 10-Q Nov 2, 2023
What the company wrote
On August 11, 2023, Andrea Sabens, our Chief Accounting Officer, entered into a 10b5-1 Plan providing for the potential sale of up to 4,093 shares of our common stock between November 13, 2023 and October 14, 2024.
Brian Markison
member of our Board of Directors
Adopted 10b5-1 plan Jun 15, 2023 10-Q Aug 3, 2023
What the company wrote
On June 15, 2023, Brian Markison, a member of our Board of Directors, entered into a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act (a “10b5-1 Plan”), providing for the potential sale of up to 10,000 shares of our common stock between September 25, 2023 and December 29, 2023.
Gérard Ber
member of our Board of Directors
Adopted 10b5-1 plan Jun 2, 2023 10-Q Aug 3, 2023
What the company wrote
On June 2, 2023, Gérard Ber, a member of our Board of Directors, entered into a 10b5-1 Plan providing for the potential sale of up to 15,500 shares of our common stock between September 5, 2023 and February 29, 2024.
Paul Blanchfield
President
Adopted 10b5-1 plan May 22, 2023 10-Q Aug 3, 2023
What the company wrote
On May 22, 2023, Paul Blanchfield, our President, entered into a 10b5-1 Plan providing for the potential sale of up to 1,908 shares of our common stock between August 21, 2023 and November 16, 2023, plus up to 33,820 shares of our common stock that may be issued pursuant to the vesting of an equity award on March 7, 2024. Pursuant to the 10b5-1 Plan, Mr. Blanchfield will also make a gift of 500 shares of common stock on March 7, 2024.
Gary Pruden
member of our Board of Directors
Adopted 10b5-1 plan May 17, 2023 10-Q Aug 3, 2023
What the company wrote
On May 17, 2023, Gary Pruden, a member of our Board of Directors, entered into a 10b5-1 Plan providing for the potential sale of up to 12,530 shares of our common stock between August 16, 2023 and July 31, 2024.
Heinz Mäusli
member of our Board of Directors
Adopted 10b5-1 plan May 16, 2023 10-Q Aug 3, 2023
What the company wrote
On May 16, 2023, Heinz Mäusli, a member of our Board of Directors, entered into a 10b5-1 Plan providing for the potential sale of up to 21,549 shares of our common stock, including shares obtained from the exercise of vested stock options covered by the 10b5-1 Plan, between August 15, 2023 and December 29, 2023.
Julie McHugh
member of our Board of Directors
Adopted 10b5-1 plan May 9, 2023 10-Q Aug 3, 2023
What the company wrote
On May 9, 2023, Julie McHugh, a member of our Board of Directors, entered into a 10b5-1 Plan providing for the potential sale of up to 2,180 shares of our common stock between August 8, 2023 and December 29, 2023.
Samuel Leno
member of our Board of Directors
Adopted 10b5-1 plan May 8, 2023 10-Q Aug 3, 2023
What the company wrote
On May 8, 2023, Samuel Leno, a member of our Board of Directors, entered into a 10b5-1 Plan providing for the potential sale of up to 26,479 shares of our common stock, including shares obtained from the exercise of vested stock options covered by the 10b5-1 Plan, between August 9, 2023 and August 31. 2023.
Mary Anne Heino
Executive Chairperson and Chief Executive Officer
Adopted 10b5-1 plan – 10-Q May 7, 2026
Show the other 21 plans

From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since May 4, 2023.

Notices of planned sales

Form 144 · Form 144 XML, SEC

What the sellers expected to sell on the Form 144 notices filed each month (the value on the notice).

FiledSellerSharesValue
Feb 2, 2026 Blanchfield Paul
Former Officer
6,713 $450K
Jan 6, 2026 Blanchfield Paul
Former Officer
7,217 $502K
Dec 12, 2025 Blanchfield Paul
Officer
3,265 $218K
Nov 26, 2025 Blanchfield Paul
Former Officer
11,776 $687K
Nov 14, 2025 Blanchfield Paul
Former Officer
16,530 $871K

From the Form 144 XML filed with the SEC, since Nov 14, 2025. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.

Sources

Regulation S-K Item 408 in the XBRL of each 10-Q and 10-K (since 2023); the Form 144 XML at the SEC.

Also

Insider trades: the Form 4s for the sales these plans led to.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/LNTH/export.csv") into a cell.

Next:Owners
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.